Sign in

CIK 0001650648

  • Non-accelerated filer
  • Smaller reporting company

4D Molecular Therapeutics, Inc.

Sign in to watch
Ticker
FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473506994
Phone
+1 510-505-2680
Business address
5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Former names
4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,616,428
in 5 filings, $1.6M under 10b5-1 plans

Net −$1,616,428. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-17 Chacko Jacob Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2025-06-17 Chacko Jacob Director Grant or award · Stock Option (Right to Buy) +22,500 22,500
2024-05-21 Chacko Jacob Director Grant or award · Stock Option (Right To Buy) +22,500 22,500
2023-05-23 Chacko Jacob Director Grant or award · Stock Option (Right to Buy) +22,500 22,500
2023-04-21 Chacko Jacob Director Exercise or conversion 10b5-1 +5,000 $9.41 $47K 5,000
2023-04-21 Chacko Jacob Director Sale 10b5-1 −5,000 $20.05 $100K 0
2023-04-21 Chacko Jacob Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −5,000 32,500
2022-05-23 Chacko Jacob Director Grant or award · Stock Option (Right to Buy) +22,500 22,500
2021-05-17 Chacko Jacob Director Grant or award · Stock Option (Right to Buy) +22,500 22,500

Page 1 of 1 · 9 trades